XELJANZ 5 mg film-coated tablets clinical trials
5 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic use (Phase IV)
Tofacitinib in early active axial spondyloarthritis: a prospective, randomized, double-blind, placebo-controlled multicentre study - FASTLANE
This study, called FASTLANE, is looking at a medicine called tofacitinib for early active ankylosing spondylitis. Researchers want to see if it helps reduce disease activity and symptoms. It compares tofacitinib with a dummy pill and a common painkiller.
For: Axial spondyloarthritisGermany · Bulgaria · Poland - Ongoing, recruitingTherapeutic use (Phase IV)
Investigating the role of JAK inhibition in achieving and maintaining disease remission in psoriatic arthritis (PsA).
This study looks at how well a medicine called XELJANZ works for psoriatic arthritis. It checks if the medicine can help people get into remission and stay there. Researchers will also see how it affects symptoms like joint and skin problems over time.
For: Psoriatic ArthritisBelgium - Ongoing, recruitingTherapeutic use (Phase IV)
A stratification trial to determine key immunological factors predicting Tofacitinib efficacy in Psoriatic Arthritis (PsA); TOFA-PREDICT
This study, called TOFA-PREDICT, looks at how a medicine called Tofacitinib works for people with Psoriatic Arthritis. Researchers want to understand why it helps some people more than others by looking at their body's chemistry before and during treatment.
For: Psoriatic arthritisNetherlands - AuthorisedPhase III and phase IV (Integrated)
IMPACT OF ANTI-TNF, VEDOLIZUMAB AND TOFACITINIB ON AORTIC STIFFNESS, CAROTID INTIMA-MEDIA THICKNESS AND CARDIOVASCULAR RISK OF PATIENTS WITH ULCERATIVE COLITIS
This study looks at how certain medicines for ulcerative colitis might affect heart and blood vessel health. We want to see if these treatments change the thickness of neck artery walls or how stiff the main heart artery is in people with ulcerative colitis.
For: ulcerative colitisFrance - AuthorisedTherapeutic confirmatory (Phase III)
Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis (SMART-JIA)
This study looks at different medicines for children and young people with JIA whose current treatment hasn't worked well enough. We want to find out which medicine best helps control their arthritis and reduces symptoms like pain and tiredness after 6 months.
For: Juvenile Idiopathic ArthritisItaly · Netherlands · Germany